PMID: 12865275

Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas.
Gut. 2003 Aug;52(8):1159-64., [PubMed]
Sentences
No. Mutations Sentence Comment
130 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:130:62
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12865275:130:118
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12865275:130:76
status: NEW
view ABCC7 p.Gly542* details
The most common mutation was ∆F508 (71.3%) followed by G551D (2.9%), G542X (2.3%), 621+1G→T (1.2%), and W1282X (1.2%). Login to comment
143 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 12865275:143:13
status: NEW
view ABCC7 p.Arg117His details
For example, R117H was noted to be present in PS patients and therefore an assumption was made that this was a mild mutation.9 From these studies it was determined that most individuals with PI have two severe CFTR mutations while those with the PS phenotype have one or two mild mutations. Login to comment
279 ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12865275:279:65
status: NEW
view ABCC7 p.Gly542* details
For example, a patient carrying a class I mutation (for example, G542X) in combination with ∆F508 (class II) was classified as class I although the genotype is in fact a compound heterozygote of class I/II. Login to comment
293 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:293:74
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 12865275:293:150
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12865275:293:127
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12865275:293:92
status: NEW
view ABCC7 p.Gly542* details
The most common mutations were: ∆F508 (in 943 chromosomes, 71.2%), G551D (39, 2.9%), G542X (31, 2.3%), 621+1G→T, W1282X (16, 1.2%), and R117H (11, 0.8%). Login to comment
294 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 12865275:294:62
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 12865275:294:112
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 12865275:294:72
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 12865275:294:123
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 12865275:294:31
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 12865275:294:104
status: NEW
view ABCC7 p.Tyr1092* details
Less common mutations included G85E and 5T (n=5 chromosomes), A455E and R1162X (n=4 chromosomes), R347, Y1092X, R334W, and V520F (n=3 chromosomes). Login to comment
307 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 12865275:307:60
status: NEW
view ABCC7 p.Gly85Glu details
This includes one patient who carries the missense mutation G85E which appears to have an indeterminate effect on pancreatic phenotype as it has been observed in patients with PS and PI phenotypes.23 All but one of 49 individuals carrying at least one mutation belonging to classes IV or V have remained PS. Login to comment
308 ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 12865275:308:52
status: NEW
view ABCC7 p.Ile1234Val details
The exception, a patient with the class IV mutation I1234V, developed PI at the age of 25 years, after symptoms of chronic pancreatitis lasting 10 years. Login to comment
309 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:309:197
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:309:533
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:309:614
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:309:829
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:309:1000
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 12865275:309:210
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 12865275:309:375
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 12865275:309:381
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 12865275:309:338
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12865275:309:782
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12865275:309:870
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12865275:309:877
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 12865275:309:664
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 12865275:309:1006
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 12865275:309:478
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 12865275:309:351
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 12865275:309:451
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 12865275:309:263
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 12865275:309:457
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 12865275:309:677
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12865275:309:590
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 12865275:309:691
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 12865275:309:300
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Glu585*
X
ABCC7 p.Glu585* 12865275:309:1213
status: NEW
view ABCC7 p.Glu585* details
ABCC7 p.Gln493*
X
ABCC7 p.Gln493* 12865275:309:948
status: NEW
view ABCC7 p.Gln493* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 12865275:309:574
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 12865275:309:652
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 12865275:309:921
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Pro67Leu
X
ABCC7 p.Pro67Leu 12865275:309:440
status: NEW
view ABCC7 p.Pro67Leu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 12865275:309:902
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 12865275:309:546
status: NEW
view ABCC7 p.Ile1234Val details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 12865275:309:704
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 12865275:309:1226
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 12865275:309:769
status: NEW
view ABCC7 p.Ala559Thr details
ABCC7 p.Asp614Gly
X
ABCC7 p.Asp614Gly 12865275:309:326
status: NEW
view ABCC7 p.Asp614Gly details
ABCC7 p.Leu1335Pro
X
ABCC7 p.Leu1335Pro 12865275:309:404
status: NEW
view ABCC7 p.Leu1335Pro details
ABCC7 p.Glu1104*
X
ABCC7 p.Glu1104* 12865275:309:1162
status: NEW
view ABCC7 p.Glu1104* details
ABCC7 p.His199Arg
X
ABCC7 p.His199Arg 12865275:309:860
status: NEW
view ABCC7 p.His199Arg details
Table 2 Genotype classification according to the functional consequences of CFTR gene mutations Pancreatic status Class I Class II Class III Class IV Class V PS F1 , 875+1G→C(2) F, F (1) F, G551D (1) F, R117H (11) F,3849+10kbC→T (5) F, G85E2 (1) F, R347H (3) F,3272-26A→G (4) F, S1251N (2) F,A445E (3) F, D614G (1) F,P574H (2) F, R347P (1) F,3120G>A (1) R117H,R117H (1) F, 5T (8) F, L1335P (1) F,2789+5G→A (1) F,P67L (1) F,R347P/R347H (1) F,V232D(2) R334W, R334W(1) PS→PI F,3659delC (1) F,F (15) F,G551D (1) F, I1234V (1) F,2184insA (1) F,R560T (1) PI F, G542X (27) F,F (365) F, G551D (28) F, 621+1G→T (13) F, R560T (7) F,R553X (7) F, N1303K (9) F, R1162X (6) F,L1077P (2) F, 3659delC (5) F, I48T (1) F, 1717-1G→A (5) F,A559T (1) F, W1282X (5) F, G85E2 (2) F, 711+1G→T (5) G551D,G551D(1) F,2184delA(4) F,H199R (1) W1282X,W1282X (4) F,I1072T(1) F,Y1092X (3) F,S549 (R75Q) (1) F,556delA (3) F, Q493X (3) F,4016InsT (3) F, 3120+1G→A (2) F, G551D/R553X (2) F,Q814X(2) F,1154insTC (2) F,441delA (1) F, 4326delTC (1) F,Q552X(1) F,3007delG (1) F,2184insA (1) F, 4010del4 (1) F,3905insT (1) F,1078delT(1) F,E1104X (1) F,3876delA (1) F,4374+1G→T (1) F,E585X (1) F, E60X (1) CFTR, cystic fibrosis transmembrane regulator; PI, pancreatic insufficiency; PS, pancreatic sufficiency. Login to comment
322 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12865275:322:60
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12865275:322:95
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12865275:322:67
status: NEW
view ABCC7 p.Gly542* details
The four next most common mutations reported in this study (G551D, G542X, 621+1G→T, and W1282X) each accounted for Table 3 Pancreatic ductular and acinar secretion classified according to the functional consequences of CFTR gene mutations Functional class n Ductular function Acinar function Fluid† (ml/kg/h) Bicarbonate‡ (mmol/kg/h) Chloride‡ (mmol/kg/h) Trypsin* (U/kg/h) Colipase* (U/kg/h) Total lipase* (U/kg/h) Class I 7 2.3 (1.5) 0.03 (0.02) 0.15 (0.14) 19 (42) 142 (201) 290 (388) Class II 33 2.9 (2.4) 0.04 (0.04) 0.21 (0.33) 31 (63) 111 (197) 202 (276) Class III 6 1.1 (0.87) 0.02 (0.02) 0.12 (0.07) 109 (256) 235 (483) 608 (1280) Class IV 14 4.0 (2.8) 0.19 (0.2) 0.32 (0.12) 1032 (768) 9840 (10698) 12563 (10461) Class V 10 4.8 (3.2) 0.12 (0.07) 0.36 (0.23) 1535 (1406) 12161 (13550) 16449 (15482) Control 21 10.0 (3.9) 0.57 (0.22) 0.62 (0.3) 2291 (836) 13036 (5958) 19767 (8623) Values are mean (SD). Login to comment
364 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 12865275:364:42
status: NEW
view ABCC7 p.Gly85Glu details
A small number of mutations (for example, G85E) are considered to be indeterminate due to their inconsistent effect on pancreatic phenotype. Login to comment